西班牙大型黑色素瘤家系队列中POT1胚系突变而非TERT启动子突变与黑色素瘤易感性相关
研究纳入228个CDKN2A野生型西班牙黑色素瘤易感家系,对POT1和TERT进行胚系突变筛查。发现4个家系携带可能致病的POT1胚系突变,而在家族性黑色素瘤中未检测到TERT启动子胚系突变。结论为1.7%的CDKN2A/CDK4野生型西班牙黑色素瘤易感家系携带可能致病的POT1突变,TERT启动子胚系突变在该人群中极为罕见。
要点
- 228个CDKN2A野生型西班牙黑色素瘤易感家系中,4个家系检出可能致病的POT1胚系突变。
- POT1突变包括错义变异c.233T>C、无义变异c.1030G>T及两个影响mRNA剪接的变异。
- 家族性黑色素瘤病例中未检测到TERT启动子胚系突变,仅1例散发性多原发黑色素瘤患者检出意义未明的TERT启动子变异。
核心结论
- 1.7%的CDKN2A/CDK4野生型西班牙黑色素瘤易感家系携带可能致病的POT1胚系突变。
- TERT启动子胚系突变在西班牙黑色素瘤家系中极为罕见。
研究设计与样本
- 纳入228个CDKN2A野生型西班牙黑色素瘤易感家系(至少两名一级或二级亲属患病)。
- 每个家系选一名患者进行POT1筛查;202个家系选一名患者进行TERT测序(26个家系因DNA耗尽或降解被排除)。
- TERT启动子测序扩展至另外30个携带CDKN2A突变的家族性黑色素瘤家系和70例有家族癌症史的散发性多原发黑色素瘤患者。
主要发现
- 共鉴定出4个家系携带可能致病的POT1胚系突变:错义变异c.233T>C(p.Ile78Thr)、无义变异c.1030G>T(p.Glu344*)以及两个变异c.255G>A(r.125_255del)和c.1792G>A(r.1791_1792insAGTA, p.Asp598Serfs*22),后两者经证实破坏POT1 mRNA剪接。
- 在一例多原发黑色素瘤患者中检测到意义未明的TERT启动子变异(c.-125C>A)。
- 在家族性黑色素瘤病例中未检测到TERT启动子胚系突变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Germline mutations in telomere-related genes such as POT1 and TERT predispose individuals to familial melanoma. OBJECTIVES: To evaluate the prevalence of germline mutations in POT1 and TERT in a large cohort of Spanish melanoma-prone families (at least two affected first- or second-degree relatives). METHODS: Overall, 228 CDKN2A wild-type melanoma-prone families were included in the study. Screening of POT1 was performed in one affected person from each family and TERT was sequenced in one affected patient from 202 families (26 families were excluded owing to DNA exhaustion/degradation). TERT promoter sequencing was extended to an additional 30 families with CDKN2A mutation and 70 patients with sporadic multiple primary melanoma (MPM) with a family history of other cancers. RESULTS: We identified four families with potentially pathogenic POT1 germline mutations: a missense variant c.233T>C (p.Ile78Thr); a nonsense variant c.1030G>T (p.Glu344*); and two other variants, c.255G>A (r.125_255del) and c.1792G>A (r.1791_1792insAGTA, p.Asp598Serfs*22), which we confirmed disrupted POT1 mRNA splicing. A TERT promoter variant of unknown significance (c.-125C>A) was detected in a patient with MPM, but no germline mutations were detected in TERT promoter in cases of familial melanoma. CONCLUSIONS: Overall, 1·7% of our CDKN2A/CDK4-wild type Spanish melanoma-prone families carry probably damaging mutations in POT1. The frequency of TERT promoter germline mutations in families with melanoma in our population is extremely rare.
引用
- Potrony M, Puig-Butille JA, Ribera-Sola M, et al. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. Br J Dermatol. 2019. PMID: 30451293. doi:10.1111/bjd.17443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。